Evidence map›Paper›PMID 38216986›Full record

ArticleBMC health services research2024

Engaging stakeholders to level up COPD care in LMICs: lessons learned from the "Breathe Well" programme in Brazil, China, Georgia, and North Macedonia.

Genevie Fernandes, Siân Williams, Peymané Adab, Nicola Gale, Corina de Jong, Jaime Correia de Sousa, K K Cheng, Chunhua Chi, Brendan G Cooper, Andrew P Dickens and 16 more

Open access · goldAbstract read
In one paragraph

Article in BMC health services research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 12 institutions in 7 countries.

Genevie Fernandes *International Primary Care Respiratory Group, London, UK. gfernan2@exseed.ed.ac.uk.
Siân Williams *International Primary Care Respiratory Group, London, UK.
Peymané AdabInstitute of Applied Health Research, University of Birmingham, Birmingham, UK.
Nicola GaleHealth Services Management Centre, School of Social Policy, College of Social Sciences, University of Birmingham, Birmingham, UK.
Corina de JongInternational Primary Care Respiratory Group, London, UK.
Jaime Correia de SousaInternational Primary Care Respiratory Group, London, UK.
K K ChengInstitute of Applied Health Research, University of Birmingham, Birmingham, UK.
Chunhua ChiDepartment of General Practice, Peking University First Hospital, Beijing, China.
Brendan G CooperLung Function & Sleep, Queen Elizabeth Hospital, Birmingham, UK.
Andrew P DickensInstitute of Applied Health Research, University of Birmingham, Birmingham, UK.
Alexandra EnocsonInstitute of Applied Health Research, University of Birmingham, Birmingham, UK.
Amanda FarleyInstitute of Applied Health Research, University of Birmingham, Birmingham, UK.
Kate JollyInstitute of Applied Health Research, University of Birmingham, Birmingham, UK.
Sue JowettInstitute of Applied Health Research, University of Birmingham, Birmingham, UK.
Maka MaglakelidzeGeorgian Respiratory Association, Tbilisi, Georgia.
Tamaz MaghlakelidzeGeorgian Respiratory Association, Tbilisi, Georgia.
Sonia MartinsFamily Medicine, ABC Medical School, São Paolo, Brazil.
Alice SitchInstitute of Applied Health Research, University of Birmingham, Birmingham, UK.
Aleksandra StamenovaFaculty of Medicine, Institute of Social Medicine, Ss. Cyril and Methodius University in Skopje, Skopje, Republic of North Macedonia.
Katarina StavrikjCenter for Family Medicine, Faculty of Medicine, Ss.Cyril and Methodius University in Skopje, Skopje, Republic of North Macedonia.
Rafael StelmachPulmonary Division, Heart Institute (InCor), Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, São Paolo, Brazil.
Alice TurnerInstitute of Applied Health Research, University of Birmingham, Birmingham, UK.
Zihan PanDepartment of General Practice, Peking University First Hospital, Beijing, China.
Hui PangDepartment of Emergency, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Jianxin ZhangDepartment of General Practice, Peking University First Hospital, Beijing, China.
Rachel E JordanInstitute of Applied Health Research, University of Birmingham, Birmingham, UK.
University of Birmingham · GBPeking University First Hospital · CNSaints Cyril and Methodius University of Skopje · MKCapital Medical University · CNFaculdade de Medicina do ABC · BRHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRNIHR Birmingham Biomedical Research Centre · GBPeking University · CNPetre Shotadze Tbilisi Medical Academy · GEQueen Elizabeth Hospital Birmingham · GBTbilisi State University · GEUniversity of Minho · PT

Funding

National Institute for Health and Care Research 16/137/95
6 · The paper itself

Abstract

backgroundEffective stakeholder engagement in health research is increasingly being recognised and promoted as an important pathway to closing the gap between knowledge production and its use in health systems. However, little is known about its process and impacts, particularly in low-and middle-income countries. This opinion piece draws on the stakeholder engagement experiences from a global health research programme on Chronic Obstructive Pulmonary Disease (COPD) led by clinician researchers in Brazil, China, Georgia and North Macedonia, and presents the process, outcomes and lessons learned. MAIN BODY: Each country team was supported with an overarching engagement protocol and mentored to develop a tailored plan. Patient involvement in research was previously limited in all countries, requiring intensive efforts through personal communication, meetings, advisory groups and social media. Accredited training programmes were effective incentives for participation from healthcare providers; and aligning research findings with competing policy priorities enabled interest and dialogue with decision-makers. The COVID-19 pandemic severely limited possibilities for planned engagement, although remote methods were used where possible. Planned and persistent engagement contributed to shared knowledge and commitment to change, including raised patient and public awareness about COPD, improved skills and practice of healthcare providers, increased interest and support from clinical leaders, and dialogue for integrating COPD services into national policy and practice.

conclusionStakeholder engagement enabled relevant local actors to produce and utilise knowledge for small wins such as improving day-to-day practice and for long-term goals of equitable access to COPD care. For it to be successful and sustained, stakeholder engagement needs to be valued and integrated throughout the research and knowledge generation process, complete with dedicated resources, contextualised and flexible planning, and commitment.

Indexed as

Developing CountriesPandemicsBrazilGeorgia (Republic)HumansRepublic of North MacedoniaCOPDLMICsResearch impactStakeholder engagementTranslation

Identifiers

PMID38216986
PMCPMC10790249
OpenAlexW4390791654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.